Editor Name: Giovanni Gigante
Country: Italy
University:
Catholic University of Sacred Heart
Designation:
International Medical Affairs Director, Therapeutic Area GI & Hepatology
Global Medical Affairs
Department:
Clinical cellular and molecular research in the field of gastroenterology and
digestive endoscopy
RESEARCH INTEREST: Digestive Endoscopy | Achalasia and other esophageal disorders |
Oral trans esophageal myotomy (POEM) | Gastroesophageal reflux disease |
Endoscopic anti-reflux treatments | Esophageal manometry | Esophageal pH-metry
| Methods of breath test in gastroenterological diseases | Therapy of
Helicobacter pylori | Irritable Bowel Syndrome | Role of probiotics in the
gastroenterological diseases | intestinal bacterial contamination |
Malabsorption and food intolerances | Celiac Disease | cirrhosis | HCC | Liver
transplantation| Marketing | Market Access | Health Economic Model| Pharma
economic model | Medical Information | Pharmaco vigilance | Middle Range
Planning (MRP)
Email: vanni.gigante@gmail.com
BIOGRAPHY:
Ph.D. - Clinical cellular and
molecular research in the field of gastroenterology and digestive endoscopy
1. The Director, Medical Affairs
is a key strategic leader within GMA SP and the Chief Medical Office (CMO)
(July 2019 - Present).
2. Member of the Country (Italy
and Southern Europe Countries) Board of Directors for Johnson & Johnson
Medical Devices (June 2018 “ June 2019).
3. Pfizer sr: Senior Medical
Manager, Regional Area (Europe East, Europe West, Japan, Singapore, Australia,
New Zeeland)Â (January 2017 - May 2018).
4. Takeda Italia SpA “Takeda
Pharmaceutical Company Limited, Via Elio Vittorini 129 “00144 Rome “ Italy.
SCIENTIFIC
SOCIETIES:
2008 present: Italian Society of
Gastroenterology (SIGE)
2008 present: Italian Association
of Young Gastroenterologists and Endoscopists (AGGEI)
2008 present: Italian Association
for the Liver Study (AISF)
2011 present: Italian Society of
Digestive Endoscopy (SIED)
2013 present: Italian Group for
the digestive system motility (GISMAD)
AWARDS AND GRANTS & ACADEMIC
FIELD
2015: Best scientific
communication award XXI National Congress FISMAD Bologna Italy
July 2014 December 2014:
Fellowship Fondazione Toniolo, Universit Cattolica del Sacro Cuore,
Policlinico Universitario Agostino Gemelli, Rome Italy
2014: Travel grant for oral
communication at 22th United European Gastroenterology week. Wien - Austria
2014: SIGE fellowship for
participation at XX National Congress FISMAD Naples Italy
Best oral communication award at
XX National Congress FISMAD Naples Italy
2013: Travel grant Alfawassermann
at XXI National Congress FISMAD Bologna Italy
2012: Clinical research fellowship
Angelini Group at UPC Internal Medicine and Gastroenterology to the study of
gelatin tannate role in antibiotic-associated diarrhea during the eradication
therapy for Helicobacter pylori
2012: SIGE fellowship XVIII
National Congress FISMAD Naples Italy
2011: SIGE fellowship XVII
National Congress FISMAD Turin Italy
2009: Travel Grant 17th United
European Gastroenterology Week London – UK
2008: Fellowship at Lega Italiana Lotta ai Tumori (LILT) for the metabolic syndrome as a risk factor for the development of sporadic colorectal cancer.
PUBLICATIONS
1- Tringali A, Barbaro F, Pizzicannella M, Boškoski I, Familiari
P, Perri V, Gigante G, Onder G, Hassan C, Lionetti R, Ettorre GM, Costamagna G.
Endoscopic management with multiple plastic stents of anastomotic biliary
stricture following liver transplantation: long-term results. Endoscopy. 2016
FebÂ
2- Familiari P, Greco S, Gigante G, Calì A, Boškoski I, Onder G,
Perri V, Costamagna G. Gastroesophageal reflux disease after peroral endoscopic
myotomy: Analysis of clinical, procedural and functional factors, associated
with gastroesophageal reflux disease and esophagitis. Digestive Endoscopy 2016;
28: 33â41
3- Familiari P, Gigante G, Marchese M, Boskoski I, Tringali A,
Perri V, Costamagna G. Per-Oral Endoscopic Myotomy for Esophageal Achalasia:
outcomes of the first 100 patients with short-term follow-up. Â
    Ann Surg. 2016 Jan;263(1):82-7
4- Familiari P, Greco S, Volkanovska A, Gigante G, Cali A,
Boškoski I, Costamagna G. Achalasia: current treatment options. Expert Rev
Gastroenterol Hepatol. 2015;9(8):1101-14.
5- Franceschi F, Zampetti A, Gigante G, Gasbarrini A. Helicobacter
pylori and small intestinal bacterial overgrowth affect gastrointestinal
symptoms in Fabry's disease. Dig Liver Dis. 2015 Mar 6. pii: S1590-8658.
6- Caldaro T, Familiari P, Romeo EF, Gigante G, Marchese M,
Contini AC, Federici di Abriola G, Cucchiara S, De Angelis P, Torroni F,
Dall'Oglio L, Costamagna G. Treatment of esophageal achalasia in children:
Today and tomorrow. J Pediatr Surg. 2015 May;50(5):726-30
7- Bove V, Tringali A, Familiari P, Gigante G, Boškoski I, Perri
V, Mutignani M, Costamagna G. ERCP in patients with prior Billroth II
gastrectomy: report of 30 years' experience. Endoscopy. 2015 Jul;47(7):611-6.
8- Gigante G, Familiari P, Marchese M, Costamagna G.Â
La miotomia endoscopica transorale (POEM) per il trattamento dell’acalasia
esofagea. Giorn Ital End Dig 2014;37:135-141
9- Cesario V, Di Rienzo TA, Campanale M, D'angelo G, Barbaro F,
Gigante G, Vitale G, Scavone G, Pitocco D, Gasbarrini A, Ojetti V. Methane
intestinal production and poor metabolic control in type I diabetes complicated
by autonomic neuropathy. Minerva Endocrinol. 2014 Sep;39(3):201-7.
10- Familiari P, Gigante G, Marchese M, Boskoski I, Bove V,
Tringali A, Perri V, Onder G, Costamagna G. EndoFLIP system for the
intraoperative evaluation of peroral endoscopic myotomy. United European
Gastroenterol J. 2014 Apr;2(2):77-83.
11- Marchese M, Minelli Grazioli L, Gigante G, Familiari P,
Costamagna G. Si rilevano disordini motori non acalasici dell’esofago.Â
Giorn Ital End Dig 2014;37:55-59Â Â
12- Campanale M, Nucera E, Ojetti V, Cesario V, Di Rienzo TA,
D'Angelo G, Pecere S, arbaro F, Gigante G, De Pasquale T, Rizzi A,
Cammarota G, Schiavino D, Franceschi F, Gasbarrini A. Nickel Free-Diet Enhances
the Helicobacter pylori Eradication Rate: A Pilot Study. Dig Dis Sci. 2014
Aug;59(8):1851-5.
13- Ianiro G, Bruno G, Lopetuso L, Beghella FB, Laterza L,
D'Aversa F, Gigante G, Cammarota G, Gasbarrini A. Role of yeasts in healthy and
impaired gut microbiota: the gut mycome. Curr Pharm Des. 2014;20(28):4565-9.
14- Familiari P, Marchese M, Gigante G, Boskoski I, Tringali A,
Perri V, Costamagna G. Peroral Endoscopic Myotomy For The Treatment of
Achalasia In Children: Report of 3 Cases. J Pediatr Gastroenterol Nutr. 2013
Aug 11.Â
15- Familiari P, Gigante G, Boskoski I, Costamagna G, La
POEM (Peroral Endoscopic Myotomy), Giorn Gastr Epatol Nutr Ped 2013;
Volume V(4):34-36
16- Bove V, Tringali A, Boškoski I, Gigante G, Costamagna
G. ESWL-assisted removal of a calcified pancreatic stent.Â
Endoscopy. 2013;45 Suppl 2 UCTN:E163.
17- Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni
E, Barbaro F, Piano C, Fortuna S, Tortora A, Di Giacopo R, Campanale M, Gigante
G, Lauritano EC, Navarra P, Marconi S, Gasbarrini A, Bentivoglio AR The role of
small intestinal bacterial overgrowth in Parkinson's disease. Mov Disord. 2013
Aug;28(9):1241-9
18- Scarpellini E, Giorgio V, Gabrielli M, Filoni S, Vitale G,
Tortora A, Ojetti V, Gigante G, Fundarò C, Gasbarrini A. Rifaximin
treatment for small intestinal bacterial overgrowth in children with irritable
bowel syndrome. Eur Rev Med Pharmacol Sci. 2013 May;17(10):1314-20.Â
19- Purchiaroni F, Tortora A, Gabrielli M, Bertucci F, Gigante G,
Ianiro G, Ojetti V, Scarpellini E, Gasbarrini A.The role of intestinal
microbiota and the immune system Eur Rev Med Pharmacol Sci. 2013
Feb;17(3):323-33.Â
20- Tortora A, Purchiaroni F, Scarpellini E, Ojetti V, Gabrielli
M, Vitale G, Gigante G, Gasbarrini A. Colitides. Eur Rev Med Pharmacol Sci.
2012 Nov;16(13):1795-805.
21- Gigante G, Scaldaferri F, Cammarota G, Gasbarrini AÂ La
supplementazione con tannato di gelatina riduce l’incidenza di eventi avversi
associati a terapia anti-H. pylori: uno studio pilota. Conference Insight Anno
X, N. 6, dicembre 2012.
22- Ojetti V, Bruno G, Ainora ME, Gigante G, Rizzo G, Roccarina D,
Gasbarrini A. Impact of Lactobacillus reuteri Supplementation on
Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. Gastroenterol
Res Pract. 2012;2012:740381.Â
23- Gigante G, Tortora A, Ianiro G, Ojetti V, Purchiaroni F,
Campanale M, Cesario V, Scarpellini E, Gasbarrini A. Role of gut microbiota in
food tolerance and allergies. Dig Dis. 2011;29(6):540-9.
24- Ojetti V, Gigante G, Gabrielli M, Ainora ME, Mannocci A,
Lauritano EC, Gasbarrini G, Gasbarrini A.The effect of oral supplementation
with Lactobacillus reuteri or tilactase in lactose intolerant patients:
randomized trial. Eur Rev Med Pharmacol Sci. 2010 Mar;14(3):163-70.
25- Ojetti V, Pitocco D, Scarpellini E, Zaccardi F, Scaldaferri F,
Gigante G, Gasbarrini G, Ghirlanda G, Gasbarrini A. Small bowel bacterial
overgrowth and type 1 diabetes. Eur Rev Med Pharmacol Sci. 2009
Nov-Dec;13(6):419-23
26- V. Ojetti , G. Gigante, M.E. Ainora, F. Fiore, F. Barbaro, A.
Gasbarrini Microflora imbalance and gastrointestinal disease Digestive and
Liver Disease Supplements 3 (2009) 9–13
27- Franceschi F, Marini M, Ursella S, Carbone L, Candelli M,
Pignataro G, Gabrielli M, Santarelli L, Ojetti V, Giupponi B, Fiore V, Barbaro
F, De Marco G, Buccelletti F, Mancini F, Roccarina D, Gigante G, Gasbarrini A,
Gasbarrini G, Silveri NG Use of oxycodone in polytrauma patients: the
"Gemelli" experience. Eur Rev Med Pharmacol Sci. 2008
Mar-Apr;12(2):123-6.
28- Franceschi F, Navarese EP, Mollo R, Gigante G,e Giupponi B, De
Marco G, Merra G, Gasbarrini G, Silveri NG. Helicobacter pylori and
atherosclerosis. A review of the literature. Gastroenterology across Europe
2008.
29- Franceschi F, Cazzato A, Nista EC, Scarpellini E, Roccarina D,
Gigante G, Gasbarrini G, Gasbarrini A Role of probiotics in patients with
Helicobacter pylori infection. Helicobacter. 2007 Nov;12 Suppl 2:59-63.
30- F. Franceschi, D. Roccarina, G. Gigante, M. Marini, B.
Giupponi, G. De Marco, F. Barbaro, A. Gasbarrini, G. Gasbarrini. I vaccini in
Gastroenterologia, Argomenti di Gastroenterologia Clinica vol. 20; n. 4;
dicembre 2007.
INTERNATIONAL CONGRESSES ORAL
COMMUNICATIONS AND POSTERS ACCEPTED ABSTRACTSÂ
1) Francesco Franceschi, Davide Roccarina, Giovanni Gigante,
Giampaolo Niccoli, Luigi Carbone, Stefano Arsella, Valentina Fiore, Gaetano
Lanza, Gregory A. Sgueglia, Luca Altamura, Micaela Conte, Giuseppe Ferrante,
Italo Porto, Antonello Leone, Giovanni Gasbarrini, Antonio Gasbarrini, Filippo
Crea, Nicolò Gentiloni Silveri Atheroscletotic Burden in Patients with
Infection Sustained By Caga-Positive Strains of H. Pylori. Poster Session,
Abstract n. S1522. Digestive Disease Week and the 108th Annual Meeting of the
America Gatroenterology Association Institute, May 19-24, 2007, Washington, DC.
Gastroenterology, April 2007, Volume 132, Number 4, Suppl. 2.
2) Francesco Franceschi, Davide Roccarina, Giovanni Gigante,
Giampaolo Niccoli, Giuseppe Ferrante, Luigi Carbone, Stefano Ursella, Valentina
Fiore, B. Fusco, Micaela Conte, Antonello Leone, Giovanni Gasbarrini, Antonio
Gasbarrini, Filippo Crea, Nicolò Gentiloni Silveri Are CagA Positive Strains
of H. Pyolri Associat4ed with Increased Risk of Ischemic Heart Disease? A
Meta-Analysis. Poster Session, Abstract n. S1525. Digestive Disease Week and
the 108th Annual Meeting of the America Gatroenterology Association Institute,
May 19-24, 2007, Washington, DC. Gastroenterology, April 2007, Volume 132,
Number 4, Suppl. 2.
3) Franceschi Francesco, Roccarina Davide, Gigante Giovanni,
Giupponi Bianca, De Marco Guido, Niccoli Giampaolo, Ferrante Giuseppe,
Fusco B, Conte Micaela, Leone AM, Gasbarrini Giovanni, Gasbarrini Aantonio,
Crea Filippo, Gentiloni Silveri Nicolò. “ Are CagA-positive strains of
Helicobacter pylori associated with increased risk of ischemic heart disease? A
meta-analysis†Helicobacter 2007 vol 12: 4 : P023 ISSN 1083-4389
4) Franceschi Francesco, Roccarina Davide, Gigante Giovanni,
Giupponi Bianca, De Marco Guido, Niccoli Giampaolo, Gaetano A. Lanza, Sgueglia
Gregory A, Altamura Luca, Conte Micaela, Ferrante Giuseppe, Porto Italo, Leone
Antonio Maria, Gasbarrini Giovanni, Gasbarrini Antonio, Crea Filippo, Gentiloni
Silveri Nicolò “Atherosclerotic burden in patients with infection sustained
by CagA-positive strains of H. pyloriâ€. †Helicobacter 2007 vol 12: 4 : W 1.07 : ISSN 1083-4389.
5) Ainora, Nista, Roccarina, Gigante, Sparano, Vitale, Barbaro,
Cammarota, Gasbarrini G, Gasbarrini A. “Impact of Lactobacillus Reuterii
Supplementation on Anti- Helicobacter Pylori Second-line Terapy Side Effectâ€. Helicobacter 2007 vol 12: 4 : P 068 : ISSN 1083-4389
6) Franceschi Francesco, Roccarina Davide, Gigante Giovanni,
Giupponi Bianca, De Marco Guido, Niccoli Giampaolo, Gaetano A. Lanza, Sgueglia
Gregory A, Altamura Luca, Conte Micaela, Ferrante Giuseppe, Porto Italo, Leone
Antonio Maria, Gasbarrini Giovanni, Gasbarrini Antonio, Crea Filippo, Gentiloni
Silveri Nicolò “Atherosclerotic burden in patients with infection sustained
by CagA-positive strains of H. pyloriâ€.
Internal and Emergency Medicine 2007 vol 2; suppl; ottobre 2007; S78
7) Franceschi Francesco, Roccarina Davide, Gigante Giovanni,
Giupponi Bianca, De Marco Guido, Niccoli Giampaolo, Ferrante Giuseppe,
Fusco B, Conte Micaela, Leone AM, Gasbarrini Giovanni, Gasbarrini Aantonio,
Crea Filippo, Gentiloni Silveri Nicolò. “ Are CagA-positive strains of
Helicobacter pylori associated with increased risk of ischemic heart disease? A
meta-analysis†Internal and Emergency Medicine 2007 vol 2; suppl; ottobre
2007; S78
8) Franceschi F., Fini, Zocco, Manno, Roccarina, Gigante G.,
Giubboni, De Marco, Barbaro, Gentiloni Silveri, Coco, Gasbarrini G., Gasbarrini
A. “ Differential espression of metalloprotinases between normal mucosa of
patient with sporadic colorectal cancer and of normal subjects: a risk factor
for neoplastic tansformation ?â€
Internal and Emergency Medicine 2007 vol 2; suppl; ottobre 2007; S78Â
9) M Novi, MA Zocco EC Lauritano, D Roccarina, ME Ainora, E
Scarpellini, G Gigante, I Leka, A Lupascu, M Gabrielli, G Cammarota, G
Gasbarrini, A Gasbarrini. “Role of small intestinal bacterial overgrowth in
patients with recurrent urogenital infection.†?†Internal and Emergency Medicine 2007 vol 2; suppl; ottobre
2007; S85Â
10) M. Novi, M. Zocco, C. Lauritano, Giovanni Gigante, E.
Scarpellini, D. Roccarina, I. Ieka, M. Ainora, A. Lupascu, E. Nista, M.
Gabrielli, G. Cammarota, G. Gasbarrini, A. Gasbarrini “Role of Small
Intestinal Bacterial Overgrow in patient with recurrent urogenital infectionâ€, ENDOSCOPY supp. 1; vol. 39; A336 GUT 2007; 56(suppl III) A 336
11) Franceschi F., Fini, Zocco, Manno, Roccarina, Gigante G.,
Giubboni, De Marco, Barbaro, Gentiloni Silveri, Coco, Gasbarrini G., Gasbarrini
A. “ Differential espression of metalloprotinases between normal mucosa of
patient with sporadic colorectal cancer and of normal subjects: a risk factor
for neoplastic tansformation ?â€
ENDOSCOPY supp. 1; vol. 39; A311,GUT 2007; 56(suppl III) A 311
12) Ainora, Nista, Roccarina, Gigante, Sparano, Vitale, Barbaro,
Cammarota, Gasbarrini G, Gasbarrini A. “Impact of Lactobacillus Reuterii
Supplementation on Anti- Helicobacter Pylori Second-line Terapy Side Effectâ€. ENDOSCOPY supp. 1; vol. 39; A101, GUT 2007; 56(suppl III)
A 101
13) Franceschi Francesco, Roccarina Davide, Gigante Giovanni,
Giupponi Bianca, De Marco Guido, Niccoli Giampaolo, Ferrante Giuseppe,
Fusco B, Conte Micaela, Leone AM, Gasbarrini Giovanni, Gasbarrini Aantonio, Crea
Filippo, Gentiloni Silveri Nicolò. “ Are CagA-positive strains of
Helicobacter pylori associated with increased risk of ischemic heart disease? A
meta-analysis†ENDOSCOPY supp. 1; vol. 39; A92, GUT 2007; 56(suppl III) A
92
14) A.Lupascu, E. Scarpellini, C. Lauritano, M. Gabrielli, C.
Petruzzellis, D. Roccarina, M.E. Ainora, G. Gigante, A. Santoliquido, R. Flore,
P Tondi, G. Cammarota, G. Gasbarrini, A. Gasbarrini, “Methane determination
increase the accuracy of hydrogen breth test: a retrospective studyâ€Â Digestive and Liver Disease 39S (2007), S139-S343,
PO.27Â
15) Franceschi Francesco, Roccarina Davide, Gigante Giovanni, ,
Niccoli Giampaolo, Ferrante Giuseppe, Fusco B, Conte M, Leone AM,
Gasbarrini Giovanni, Gasbarrini Aantonio, Crea Filippo, Gentiloni Silveri
Nicolò. “ Are CagA-positive strains of Helicobacter pylori associated with
increased risk of ischemic heart disease? A meta-analysisâ€Â Digestive and Liver Disease 39S (2007), S139-S343, PO.13
16) Franceschi Francesco, Roccarina Davide, Gigante Giovanni,
Niccoli Giampaolo, Gaetano A. Lanza, Sgueglia Gregory A, Altamura Luca, Conte
Micaela, Ferrante Giuseppe, Porto Italo, Leone Antonio Maria, Gasbarrini
Giovanni, Gasbarrini Antonio, Crea Filippo, Gentiloni Silveri Nicolò “Atherosclerotic
burden in patients with infection sustained by CagA-positive strains of H.
pyloriâ€. Digestive and Liver Disease 39S (2007), S139-S343,
PA.28Â Â
17) G Vitale, M Novi, V Cesario, EC Lauritano, D Roccarina, ME
Ainora, E Scarpellini, G Gigante, I Leka, A Lupascu, M Gabrielli, G Cammarota,
G Gasbarrini, A Gasbarrini. “Role of small intestinal bacterial overgrowth in
patients with recurrent urogenital infection. ?â€Â Poster Session PA.49 XIV Congresso Nazionale delle
Malattie Digestive Digestive and Liver Disease, Volume 40, Supplement 1, March
2008, Page S42
18) Ainora, Nista, Roccarina, Gigante, Sparano, Vitale, Barbaro,
Cammarota, Gasbarrini G, Gasbarrini A. “Impact of Lactobacillus Reuterii
Supplementation on Anti- Helicobacter Pylori Second-line Terapy Side Effectâ€. Poster Session PA.29 XIV Congresso Nazionale delle
Malattie Digestive Digestive and Liver Disease, Volume 40, Supplement 1, March
2008, Page S13
19) Franceschi F., Fini, Zocco, Manno, Roccarina, Gigante G.,
Giubboni, De Marco, Barbaro, Gentiloni Silveri, Coco, Gasbarrini G., Gasbarrini
A. “ Differential espression of metalloprotinases between normal mucosa of
patient with sporadic colorectal cancer and of normal subjects: a risk factor
for neoplastic tansformation ?â€Â
Poster Session PA.130 XIV Congresso Nazionale delle Malattie Digestive
Digestive and Liver Disease, Volume 40, Supplement 1, March 2008, Page S23.
20) Franceschi F, Gigante G, Roccarina D, Vitale G, Ainora ME,
Lauritano C, Zampetti A, Antuzzi D, De Marco G, Gipponi B, Feliciani C,
Gentiloni Silveri N, Gasbarrini G, Gasbarrini A “Fabry disease and small
intestinal bacterial overgrowth: prevalence and correlation with
gastrointestinal symptmsâ€Â Poster Session
PA.186 XIV Congresso Nazionale delle Malattie Digestive Digestive and Liver
Disease, Volume 40, Supplement 1, March 2008, Page S67.
21) Franceschi F, Gigante G, Roccarina D, Vitale G, Ainora ME,
Lauritano C, Di simone N,D’Alessio MC, De Marco G, Gipponi B, Carusa A,
Gentiloni Silveri N, Gasbarrini G, Gasbarrini A Cag AA-positive strains of H
Pylori affect trophoblast cells invasiveness: do they play a role in
pre-ecampsia and poliabortivity) Oral Presentation OC3.02 XIV Congresso
Nazionale delle Malattie Digestive Digestive and Liver Disease, Volume 40,
Supplement 1, March 2008, Page S92.
22) Ojetti V, Gigante G, Ainora ME, Migneco, Scarpellini E,
Gasbarrini G, Gasbarrini A. The effects of oral supplementation wirh
lactobacillus reuterii or tilactase in lactose- intolerance patients: placebo
controlled study Oral Presentation OC3.09 XIV Congresso Nazionale delle
Malattie Digestive Digestive and Liver Disease, Volume 40, Supplement 1, March
2008, Page S34
23) Sparano L, Cazzato A, Lauritano EC, Scrpellini E, Gigante G,
Cammarota G, De Lorenzo A, GasbarriniG, Gasbarrini A, Small intestinal
bacterial overgrowth (SIBO) can affect intestinal permeability. Poster Session
PA.58 XIV Congresso Nazionale delle Malattie Digestive Digestive and Liver
Disease, Volume 40, Supplement 1, March 2008, Page S52
24) Scalpellini E, Fundarò C, GiorgioV, Panzanella A, Cesario V,
Lauritano C, Roccarina D, Novi L, Ainora ME, Gargovich M, Gigante G, Cammarota
G, Gasbarrini G, Ghirlanda G, Gasbarrini A. Small intestinal bacterial
overgrowth (SIBO) in a children population affected by irritable bowel
syndrome: a case-control study Oral Presentation OC3.08 XIV Congresso Nazionale
delle Malattie Digestive Digestive and Liver Disease, Volume 40, Supplement 1,
March 2008, Page S15
25) Cazzato A ,Sparano L, Lauritano EC, Scrpellini E, Gigante G,
Cammarota G, De Lorenzo A, GasbarriniG, Gasbarrini A Small intestinal bacterial
overgrowth (SIBO) can affect intestinal permeability Poster Session, Abstract
n. 442383. Digestive Disease Week and the 109th Annual Meeting of the America
Gatroenterology Association Institute, May 19-24, 2008, San Diego,
California.Â
26) Scalpellini E, Fundarò C, GiorgioV, Panzanella A, Cesario V,
Lauritano C, Roccarina D, Novi L, Ainora ME, Gargovich M, Gigante G, Cammarota
G, Gasbarrini G, Ghirlanda G, Gasbarrini A. Small intestinal bacterial
overgrowth (SIBO) in a children population affected by irritable bowel
syndrome: a case-control study. Poster Session, Abstract n. 441872. Digestive
Disease Week and the 109th Annual Meeting of the America Gatroenterology
Association Institute, May 19-24, 2008, San Diego, California.Â
27) Francesco Franceschi, Giovanni Gigante, Nicoletta Di Simone,
Davide Roccarina, Maria Chiara D'Alessio, Marco Marini, Bianca Giupponi,
Floriana Mancini, Guido De Marco, Federico Barbaro, Valentina Fiore, Roberta
Castellani, Giovanni Gasbarrini, Antonio Gasbarrini, Alessandro Caruso, Nicolò
Gentiloni Silveri. CAGA-POSITIVE STRAINS OF H. PYLORI AFFECT TROPHOBLAST
CELLSÂ INVASIVENESS: DO THEY PLAY A ROLE IN PRE-ECLAMPSIA ANDÂ
POLIABORTIVITY? Digestive Disease Week (DDW), may 17-22, 2008, San
Diego, California.Citation: Gatroenterology, maggio 2008
28) F. Franceschi, G. Gigante, D. Roccarina, A. Zampetti, D.
Antuzzi, G. Vitale, M.E. Ainora, V. Cesario, E.C. Lauritano, G. De Marco, B.
Giupponi, C. Feliciani, G. Gasbarrini, A. Gasbarrini FABRY DISEASE INFECTION
AND SMALL INTESTINAL BACTERIAL OVERGROWTH IN PATIENTS WITH FABRY’S DISEASE:
DO THEY ENHANCE THE EXPRESSION OF FABRY-RELATED GASTROINTESTINAL SYMPTOMS?
Abstract: W4.1Â XXIth International Workshop on Helicobacter and related
bacteria in chronic digestive inflammation, Riga (Latvia), 18-21
settembre 2008.   Citation: Helicobacter, Volume 13,
Number 5, October 2008.
28) F. Franceschi, G. Gigante, N. Di Simone, D. Roccarina, M.
D’Alessio, Y. Yamaoka, M. Marini, B. Gipponi, F. Mancini, G. De Marco, F.
Barbaro, V. Fiore, R. Castellani, G. Gasbarrini, A. Gasbarrini, A. Caruso, N.
Gentiloni SilveriCAGA-POSITIVE STRAINS OF H.PYLORI IMPAIR TROPHOBLAST CELLS
INVASIVENESS: DO THEY PLAY A ROLE IN PRE-ECLAMPSIA AND POLIABORTIVITY?
Abstract: P029Â XXIth International Workshop on Helicobacter and related
bacteria in chronic digestive inflammation, Riga (Latvia), 18-21
settembre 2008.   Citation: Helicobacter, Volume 13,
Number 5, October 2008.
29) Ainora, Nista, Roccarina, Gigante, Sparano, Vitale, Barbaro,
Cammarota, Gasbarrini G, Gasbarrini A. “Impact of Lactobacillus Reuterii
Supplementation on Anti- Helicobacter Pylori Second-line Terapy Side Effectâ€. Workshop on Helicobacter and related bacteria in chronic
digestive inflammation, Riga (Latvia), 18-21 settembre 2008. Citation:
Helicobacter, Volume 13, Number 5, October 2008
30) F. Franceschi, G. Gigante, D. Roccarina, A. Zampetti, D.
Antuzzi, G. Vitale, M.E. Ainora, V. Cesario, E.C. Lauritano, G. De Marco, B.
Giupponi, C. Feliciani, G. Gasbarrini, A. Gasbarrini FABRY DISEASE INFECTION
AND SMALL INTESTINAL BACTERIAL OVERGROWTH IN PATIENTS WITH FABRY’S DISEASE:
DO THEY ENHANCE THE EXPRESSION OF FABRY-RELATED GASTROINTESTINAL
SYMPTOMS?Abstract: P0070Â 16th UNITED EUROPEAN GASTROENTEROLOGY WEEK
Vienna, 18-22 Ottobre 2008Citation: GUT, Volume 57, Supplement, October 2008
31) F. Franceschi, G. Gigante, N. Di Simone, D. Roccarina, M.
D’Alessio, Y. Yamaoka, M. Marini, B. Gipponi, F. Mancini, G. De Marco, F.
Barbaro, V. Fiore, R. Castellani, G. Gasbarrini, A. Gasbarrini, A. Caruso, N.
Gentiloni SilveriCAGA-POSITIVE STRAINS OF H.PYLORI IMPAIR TROPHOBLAST CELLS
INVASIVENESS: DO THEY PLAY A ROLE IN PRE-ECLAMPSIA AND POLIABORTIVITY?Abstract:
P0071Â 16th UNITED EUROPEAN GASTROENTEROLOGY WEEK Vienna, 18-22 Ottobre
2008Â Â Â Citation: GUT, Volume 57, Supplement, October 2008.
32) E. Scarpellini, C. Fundarò, V. Giorgio, A. Pantanella,
Ernesto Cristiano Lauritano, Davide Roccarina, Marialuisa Novi, M. Ainora,
Giovanni Gigante, Matteo Garcovich, G. Merra, Giovanni Cammarota, Giovanni
Gasbarrini, Antonio Gasbarrini. SMALL INTESTINAL BACTERIAL OVERGROWTH IN
IRRITABLE BOWEL SYNDROME CHILDREN POPULATION: A CASE CONTROL STUDY Abstract:
P0577 16th UNITED EUROPEAN GASTROENTEROLOGY WEEK Vienna, 18-22 Ottobre 2008
Citation: GUT, Volume 57, Supplement, October 2008.
33) A.I. Cazzato, E.C. Lauritano, G. Vitale, M. Garcovich, D.
Roccarina, G. Gigante, G. Cammarota, A. De Lorenzo, GB.Gasbarrini, A.
Gasbarrini SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) IN PATIENTS WITHÂ
 DUODENOGASTRIC REFLUX (DGR)  Abstract: P1049 16th UNITED
EUROPEAN GASTROENTEROLOGY WEEKÂ Â Vienna, 18-22 Ottobre 2008Â
Citation: GUT, Volume 57, Supplement, October 2008
34) F. Franceschi, G. Gigante, N. Di Simone, D. Roccarina, M.
D’Alessio, M. Marini, B. Gipponi, F. Mancini, G. De Marco, F. Barbaro, V.
Fiore, R. Castellani, G. Gasbarrini, A. Gasbarrini, A. Caruso, N. Gentiloni
Silveri CAGA-POSITIVE STRAINS OF H.PYLORI IMPAIR TROPHOBLAST CELLS
INVASIVENESS: DO THEY PLAY A ROLE IN PRE-ECLAMPSIA AND POLIABORTIVITY? “109°
CONGRESSO NAZIONALE DELLA SOCIETA’ ITALIANA DI MEDICINA INTERNA†Genova, 25-28 Ottobre 2008, Internal and Emergency Medicine; vol
3: supplemento Ottobre 2008.
35) F. Franceschi, G. Gigante, D. Roccarina, A. Zampetti, D.
Antuzzi, G. Vitale, M.E. Ainora, V. Cesario, E.C. Lauritano, G. De Marco, B.
Giupponi, C. Feliciani, G. Gasbarrini, A. Gasbarrini  FABRY
DISEASE INFECTION AND SMALL INTESTINAL BACTERIAL OVERGROWTH IN PATIENTS WITH
FABRY’S DISEASE: DO THEY ENHANCE THE EXPRESSION OF FABRY-RELATED
GASTROINTESTINAL SYMPTOMS? “109° CONGRESSO NAZIONALE DELLA SOCIETA’
ITALIANA DI MEDICINA INTERNA†Genova, 25-28 Ottobre
2008. Internal and Emergency Medicine; vol 3: supplemento Ottobre 2008.
36) E. Scarpellini, C. Fundarò, V. Giorgio, A. Pantanella, V.
Cesario, Davide Roccarina, Ernesto Cristiano Lauritano, L. Sparano, Marialuisa
Novi,G. Gigante M. Ainora, Matteo Garcovich, F. Fiore, Giovanni Cammarota,
Giovanni Gasbarrini, Antonio Gasbarrini. SMALL INTESTINAL BACTERIAL OVERGROWTH
IN IRRITABLE BOWEL SYNDROME CHILDREN POPULATION: A CASE CONTROL STUDY “109°
CONGRESSO NAZIONALE DELLA SOCIETA’ ITALIANA DI MEDICINA INTERNA†Genova, 25-28 Ottobre 2008 Internal and Emergency Medicine; vol
3: supplemento Ottobre 2008.
37) Ainora, Nista, Roccarina, Gigante, Sparano, Vitale, Barbaro,
Cammarota, Gasbarrini G, Gasbarrini A. “Impact of Lactobacillus Reuterii
Supplementation on Anti- Helicobacter Pylori Second-line Terapy Side Effectâ€. “109° CONGRESSO NAZIONALE DELLA SOCIETA’ ITALIANA DI
MEDICINA INTERNA†Genova, 25-28 Ottobre 2008 Internal and Emergency Medicine;
vol 3: supplemento Ottobre 2008.
38) Ojetti V, Gigante G, Ainora ME, Migneco, Scarpellini E,
Gasbarrini G, Gasbarrini A. “The effects of oral supplementation wirh
lactobacillus reuterii or tilactase in lactose- intolerance patients: placebo controlled
study†“109° CONGRESSO NAZIONALE DELLA SOCIETA’ ITALIANA DI
MEDICINA INTERNA†Genova, 25-28 Ottobre 2008 Internal and Emergency Medicine;
vol 3: supplemento Ottobre 2008.
39) CDNA MICROARRAY ANALYSIS AS A NEWTOOL TO PREDICT LYMPH NODE METASTASIS
IN GASTRIC CANCER V. Ojetti ∗ , R. Persiani, F. Cananzi, S. Rausei, G.
Gigante, M.E. Ainora, F. Franceschi, G. Gasbarrini, D. D’Ugo, A. Gasbarrini
Digestive and Liver Disease 41S (2009), S1–S167.
40) ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES FROM CELIAC PATIENTS
ARE RESPONSIBLE OF TROPHOBLAST DAMAGE VIA APOPTOSIS IN VITRO: A POSSIBLE ROLE
FOR INFERTILITY, EARLY PREGNANCY LOSS AND INTRAUTERINE GROWTH RETARDATION? F.
Franceschi ∗ ,1, N. Di Simone1, D. Roccarina 1, G. Gigante , B. Giupponi1, G.
De Marco1, M. Silano2, R. Castellani 1, F. Di Nicuolo 1, M.C. D’Alessio1, A.
Tritarelli 1, A.M. Leone1, V. Ojetti 1 , G. Gasbarrini 1 , N. Gentiloni Silveri
1, A. Caruso1, A. Gasbarrini1 Digestive and Liver Disease 41S (2009),
S1–S167.
41) N-ACETIL-CYSTEINE PRE-TREATMENT AND TISSUE CULTURE
INDICATIONS-BASED APPROACH FOR THE ERADICATION OF SEVERAL THERAPIES-RESISTANT
HELICOBACTER PYLORI G. Cammarota 1, G. Ianiro1, A. Cazzato 1 , A.C. Piscaglia 1
, C. Lauritano 1, G. Gigante, F. Fiore1, F.Barbaro1, F. Ardito2, G. Branca2, R.
Torelli2, G. Fadda2, G. Gasbarrini 1, A. Gasbarrini 1 1Catholic University,
Department of Internal Medicine, Roma; 2Catholic University, Institute of
Microbiology, Roma. Digestive and Liver Disease 41S (2009), S1–S167
42) METABOLIC SYNDROME PROMOTES PRE-NEOPLASTIC CHANGES OF THE
COLONIC MUCOSA E. De Masi 1, F. Franceschi ∗ ,2, M.G. Mancino 1, G.
Cammarota2 , A. Cazzato 2 , D. Roccarina 2 , G. Gigante 2, B. Giupponi 2, G. De
Marco2, A. Gasbarrini 2, G. Gasbarrini2 1Ospedale San Carlo, Roma; 2Ospedale
Gemelli, Roma Digestive and Liver Disease 41S (2009), S1–S167.
43) H. PYLORI INFECTION AND SMALL INTESTINE BACTERIAL OVERGROWTH
IN PATIENTS WITH FABRY’ DISEASE: DO THEY ENHANCE THE EXPRESSION OF
FABRY’-RELATED GASTROINTESTINAL SYMPTOMS? F. Franceschi ∗ , G. Gigante, D.
Roccarina, A. Zampetti, D. Antuzzi, G. Vitale, M.E. Ainora, V. Cesario, C.
Lauritano, G. De Marco, B. Giupponi, V. Ojetti, C. Feliciani, G. Gasbarrini, A.
Gasbarrini, N. Gentiloni Silveri Digestive and Liver Disease 41S (2009),
S1–S167
44) CAGA-POSITIVE STRAINS OF H. PYLORI CROSS REACT WITH
TROPHOBLAST CELLS: A ROLE FOR PRE-ECLAMPSIA AND POLYABORTIVITY? F. Franceschi
∗ , N. Di Simone, G. Gigante, D. Roccarina, B. Giupponi, G. De Marco, R.
Castellani, M.C. D’Alessio, F. Di Nicuolo, S. D’Ippolito, C. Tersigni, G.
Gasbarrini, A. Gasbarrini, A. Caruso, N. Gentiloni Silveri. Digestive and Liver
Disease 41S (2009), S1–S167
45) CYCLIC TREATMENT WITH MESALAZINE IN PREVENTING RECURRENCE OF
SMALL INTESTINAL BACTERIALÂ OVERGROWTH AFTER ANTIBIOTIC TREATMENT A.
Cazzato ∗ , G. Gigante, C. Lauritano, G. Vitale, V. Cesario, F. Barbaro, G.
Cammarota, G. Gasbarrini, A. Gasbarrini Digestive and Liver Disease 41S (2009),
S1–S167
46) F. Franceschi , N. Di Simone, D. Roccarina , G. Gigante , B.
Giupponi, G. De Marco, M. Silano, R. Castellani , F. Di Nicuolo , M.C.
D’Alessio, A. Tritarelli , A.M. Leone, V. Ojetti , G.
Gasbarrini , N. Gentiloni Silveri , A. Caruso, A. Gasbarrini1ANTI-TISSUE
TRANSGLUTAMINASE ANTIBODIES FROM CELIAC PATIENTS ARE RESPONSIBLE OF TROPHOBLAST
DAMAGE VIA APOPTOSIS IN VITRO: A POSSIBLE ROLE FOR INFERTILITY, EARLY PREGNANCY
LOSS AND INTRAUTERINE GROWTH RETARDATION? Digestive Disease Week and the 110th
Annual Meeting of the America Gatroenterology Association Institute, May, 2009,
Chicago,USA.Â
47) F. Franceschi ∗ , N. Di Simone, G. Gigante, D. Roccarina, B.
Giupponi, G. De Marco, R. Castellani, M.C. D’Alessio, F. Di Nicuolo, S.
D’Ippolito, C. Tersigni, G. Gasbarrini, A. Gasbarrini, A. Caruso, N.
Gentiloni Silveri CAGA-POSITIVE STRAINS OF H. PYLORI CROSS REACT WITH
TROPHOBLAST CELLS: A ROLE FOR PRE-ECLAMPSIA AND POLYABORTIVITY? Digestive
Disease Week and the 110th Annual Meeting of the America Gatroenterology
Association Institute, May, 2009, Chicago,USA.Â
48) F. Franceschi , G. Gigante, D. Roccarina, A. Zampetti,
D. Antuzzi, G. Vitale, M.E. Ainora, V. Cesario, C. Lauritano, G. De Marco, B.
Giupponi, V. Ojetti, C. Feliciani, G. Gasbarrini, A. Gasbarrini, N. Gentiloni
Silveri H. PYLORI INFECTION AND SMALL INTESTINE BACTERIAL OVERGROWTH IN
PATIENTS WITH FABRY’ DISEASE: DO THEY ENHANCE THE EXPRESSION OF
FABRY’-RELATED GASTROINTESTINAL SYMPTOMS? Digestive Disease Week and the
110th Annual Meeting of the America Gatroenterology Association Institute, May,
2009, Chicago, USA.Â
49) Ojetti V, Gigante G, Ainora ME, Migneco, Scarpellini E,
Gasbarrini G, Gasbarrini A. “THE EFFECTS OF ORAL SUPPLEMENTATION WIRH
LACTOBACILLUS REUTERII OR TILACTASE IN LACTOSE- INTOLERANCE PATIENTS: PLACEBO
CONTROLLED STUDY†Digestive Disease Week and the 110th Annual Meeting of the
America Gatroenterology Association Institute, May, 2009, Chicago,USA.Â
50) Franceschi F., Fini, Zocco, Manno, Roccarina, Gigante G.,
Giubboni, De Marco, Barbaro, Gentiloni Silveri, Coco, Gasbarrini G., Gasbarrini
A. “ Differential espression of metalloprotinases between normal mucosa of
patient with sporadic colorectal cancer and of normal subjects: a risk factor
for neoplastic tansformation ?†Eur.
Rev. Med. Pharmacol. Sci.; 2009; 13 (Suppl 1): 109.
51) Franceschi Francesco, Roccarina Davide, Gigante Giovanni,
Giupponi Bianca, De Marco Guido, Niccoli Giampaolo, Ferrante Giuseppe,
Fusco B, Conte Micaela, Leone AM, Gasbarrini Giovanni, Gasbarrini Aantonio,
Crea Filippo, Gentiloni Silveri Nicolò. “ Are CagA-positive strains of
Helicobacter pylori associated with increased risk of ischemic heart disease? A
meta-analysisâ€Â Eur. Rev. Med. Pharmacol. Sci.; 2009; 13 (Suppl 1):
108.
52) Franceschi Francesco, Roccarina Davide, Gigante Giovanni,
Giupponi Bianca, De Marco Guido, Niccoli Giampaolo, Gaetano A. Lanza, Sgueglia
Gregory A, Altamura Luca, Conte Micaela, Ferrante Giuseppe, Porto Italo, Leone
Antonio Maria, Gasbarrini Giovanni, Gasbarrini Antonio, Crea Filippo, Gentiloni
Silveri Nicolò “Atherosclerotic burden in patients with infection sustained
by CagA-positive strains of H. pyloriâ€.Â
Eur. Rev. Med. Pharmacol. Sci.; 2009; 13 (Suppl 1): 106.
53) F. Franceschi, G. Gigante, N. Di Simone, D. Roccarina, M.
D’Alessio, M. Marini, B. Gipponi, F. Mancini, G. De Marco, F. Barbaro, V.
Fiore, R. Castellani, G. Gasbarrini, A. Gasbarrini, A. Caruso, N. Gentiloni
Silveri CAGA-POSITIVE STRAINS OF H.PYLORI IMPAIR TROPHOBLAST CELLS
INVASIVENESS: DO THEY PLAY A ROLE IN PRE-ECLAMPSIA AND POLIABORTIVITY? Eur.
Rev. Med. Pharmacol. Sci.; 2009; 13 (Suppl 1): 107.
54) Ojetti V, Gigante G, Ainora ME, Migneco, Scarpellini E,
Gasbarrini G, Gasbarrini A. “THE EFFECTS OF ORAL SUPPLEMENTATION WIRH
LACTOBACILLUS REUTERII OR TILACTASE IN LACTOSE- INTOLERANCE PATIENTS: PLACEBO
CONTROLLED STUDY†Eur. Rev. Med. Pharmacol. Sci.; 2009; 13 (Suppl 1): 100
55) Ainora, Nista, Roccarina, Gigante, Sparano, Vitale, Barbaro,
Cammarota, Gasbarrini G, Gasbarrini A. “Impact of Lactobacillus Reuterii
Supplementation on Anti- Helicobacter Pylori Second-line Terapy Side Effectâ€. Eur. Rev. Med. Pharmacol. Sci.; 2009; 13 (Suppl 1): 101
56) Franceschi F, Gigante G, Roccarina D, Vitale G, Ainora ME,
Lauritano C, Zampetti A, Antuzzi D, De Marco G, Gipponi B, Feliciani C,
Gentiloni Silveri N, Gasbarrini G, Gasbarrini A “Fabry disease and small
intestinal bacterial overgrowth: prevalence and correlation with gastrointestinal
symptms†Eur. Rev. Med. Pharmacol. Sci.; 2009; 13 (Suppl 1): 97
57) Franceschi, Roccarina, Gigante, de Marco, Marini, Giupponi,
Barbaro, Fiore, A. Gasbarrini, G. Gasbarrini. “Microbiota and colon cancer.†Eur. Rev. Med. Pharmacol. Sci.; 2009; 13 (Suppl 1): 95
58) Sparano, Cazzato, Lauritano, Scarpellini, Gigante, Cammarota,
Valenza, De Lorenzo, G. Gasbarrini, A. Gasbarrini “Small intestinal bacterial
overgrow (SIBO) can affect intestinal permeabilità †Eur. Rev. Med. Pharmacol. Sci.; 2009; 13 (Suppl 1): 94
59) Vitale, Novi, Cesario, Lauritano, Rinninella, Ainora, Gigante,
Campanale, D’Alessio, De Simone, Mancuso, Cammarota, G. Casbarrini, G.
Ghirlanda, A. Gasbarrini. “Lactose malabsorption in patient affected by
reccurent vaginitis†Eur. Rev. Med. Pharmacol. Sci.; 2009; 13 (Suppl 1): 91
60) Franceschi F, Di Caro S, Roccarina D, Gigante G, Giupponi B,
Mucci L, De Marco G, Barbaro F, Zocco MA, Gasbarrini A, Gasbarrini G “Effects
of probiotics on intestinal gene expression pattern of healthy individuals†International Journal of Probiotics & Prebiotics; Vol 3: Aug
2008, n. 3.
61) Francesco Franceschi, Nicoletta Di Simone, Giovanni Gigante,
Davide Roccarina, Bianca Giupponi, Veronica Ojetti, Guido De Marco, Federico
Barbaro, Roberta Castellani, Maria Clara D'Alessio, Fiorella Di Nicuolo, Silvia
D'Ippolito, Chiara Tersigni, Giovanni Gasbarrini, Antonio Gasbarrini,
Alessandro Caruso, Nicolò Gentiloni Silveri CagA-Positive Strains of H. pylori
Cross React with Trophoblast Cells: A Role for Pre-Eclampsia and
Poliabortivity?. Gastroenterology Vol. 136, Issue 5, Supplement 1, Page A-550
2009
62) Veronica Ojetti, Nathalie Saulnier, Roberto Persiani,
Francesco Franceschi, Giovanni Gigante, Ferdinando Cananzi, Raffaele Landolfi,
Giovanni Gasbarrini, Domenico D'Ugo, Antonio Gasbarrini. CDNA Microarray
Analysis As a New Tool to Predict Lymph Node Metastasis in Gastric Cancer.
Gastroenterology Vol. 136, Issue 5, Supplement 1, Page A-321 2009
63) Giovanni Cammarota, Gianluca Ianiro, Alessia Cazzato, Anna C.
Piscaglia, Cristiano Lauritano, Giovanni Gigante, Francesca Fiore, Federico
Barbaro, Fausta Ardito, Giovanna Branca, Riccardo Torelli, Giovanni Fadda,
Giovanni Gasbarrini, Antonio Gasbarrini Pre-Treatment with N-Acetil-Cysteine
and Culture-Guided Rescue Therapy for Eradication of Helicobacter pylori
Infection. Gastroenterology Vol. 136, Issue 5, Supplement 1, Page A-345 2009
64) Veronica Ojetti, Giovanni Gigante, Maria Elena Ainora,
Maurizio Gabrielli, Alessio Migneco, Giovanni Gasbarrini, Nicolo Gentiloni
Silveri, Antonio Gasbarrini. The Effect of Oral Supplementation with
Lactobacillus Reuteri or Tilactase in Lactose-Intolerant Patients: A Placebo
Controlled Study, Gastroenterology Vol. 136, Issue 5, Supplement 1, Page A-214
2009.
65) Emidio Scarpellini, Carlo Fundarò, Valentina Giorgio,
Maurizio Gabrielli, Ernesto Cristiano Lauritano, Davide Roccarina, Giovanni
Gigante, Federico Barbaro, Emanuele Rinninella, Gianluca Ianiro, Raffaele
Landolfi, Giovanni Gasbarrini, Antonio Gasbarrini. Small Intestinal Bacterial
Overgrowth in a Children Population Affected By Irritable Bowel Syndrome: A
Case-Control Study, Gastroenterology Vol. 136, Issue 5, Supplement 1, Page
A-370 2009.
66) Francesco Franceschi, Giovanni Gigante, Davide Roccarina, Anna
Zampetti, Daniela Antuzzi, Giovanna Vitale, Maria Elena Ainora, Valentina
Cesario, Cristiano Lauritano, Guido D. Marco, Bianca Giupponi, Veronica Ojetti,
Federico Barbaro, Claudio Feliciani, Giovanni Gasbarrini, Antonio Gasbarrini,
Nicolò Gentiloni Silveri, H. pylori Infection and Small Intestine Bacterial
Overgrowth in Patients with Fabry' Disease: Do They Enhance the Expression of
Fabry'-Related Gastrointestinal Symptoms?, Gastroenterology Vol. 136, Issue 5,
Supplement 1, Page A-264 2009
67) Francesco Franceschi, Nicoletta Di Simone, Davide Roccarina,
Giovanni Gigante, Bianca Giupponi, Guido De Marco, Veronica Ojetti, Federico
Barbaro, Marco Silano, Roberta Castellani, Fiorella Di Nicuolo, Maria Clara
D'Alessio, Alessandra Tritarelli, Antonello M Leone, Giovanni Gasbarrini,
Nicolò Gentiloni Silveri, Alessandro Caruso, Antonio Gasbarrini, Anti-Tissue
Transglutaminase Antibodies from Celiac Patients Are Responsible of Trophoblast
Damage via Apoptosis In Vitro: A Possible Role for Infertility, Early Pregnancy
Loss and Intrauterine Growth Retardation? Gastroenterology Vol. 136, Issue 5,
Supplement 1, Page A-469 2009.
68) Immacolata A. Cazzato, Giovanni Gigante, Cristiano Lauritano,
Federico Barbaro, Valentina Cesario, Giovanni Cammarota, Giovanni Gasbarrini,
Antonio Gasbarrini, Cyclic Treatment with Mesalazine in Preventing Recurrence
of Small Intestinal Bacterial Overgrowth After Antibiotic Treatment,
Gastroenterology Vol. 136, Issue 5, Supplement 1, Page A-409 2009.
69) Emidio Scarpellini, Valentina Giorgio, Simona Filoni, Veronica
Ojetti, Maurizio Gabrielli, Giovanni Gigante, Ernesto Cristiano Lauritano,
Federico Barbaro, Giovanni Gasbarrini, Carlo Fundarò, Antonio Gasbarrini,
Efficacy of Rifaximin for SIBO Treatment in IBS Children, Gastroenterology Vol.
138, Issue 5, Supplement 1, Page S-763 2010.
70) Ercole de Masi, Francesco Franceschi, Maria A. Mancini,
Giovanni Cammarota, Immacolata A. Cazzato, Davide Roccarina, Giovanni Gigante,
Bianca Giupponi, Guido de Marco, Antonio Gasbarrini, Nicolò Gentiloni Silveri,
Giovanni Gasbarrini Metabolic Syndrome Promotes the Occurrence of Pre-Neopastic
Lesions of the Colonic Mucosa, Gastroenterology Vol. 138, Issue 5, Supplement
1, Page S-293 2010
71) Maria Assunta Zocco, Andrea Lupascu, Laura Riccardi, Anna C.
Piscaglia, Luisa Siciliani, Marialuisa Novi, Ernesto Cristiano Lauritano,
Annalisa Tortora, Giovanni Gigante, Michele Cosimo Santoro, Emanuele
Rinninella, Maria Elena Ainora, Francesca R. Ponziani, Maurizio Pompili, Gian
Ludovico Rapaccini, Antonio Gasbarrini, Dynamic Contrast Enhanced Ultrasound in
Monitoring HCC Patients Treated With Sorafenib: Preliminary Results,
Gastroenterology Vol. 138, Issue 5, Supplement 1, Pages S-813-S-814 2010
72) Mariachiara Campanale, Federico Barbaro, Valentina Cesario,
Michele La Torre, Alessandra Guerra, Teresa Antonella Di Rienzo, Silvia Pecere,
Giovanni Gigante, Francesca D'Aversa, Francesca Romana Ponziani, Emanuele
Rinninella, Massimo Siciliano, Brigida E. Annicchiarico, Maria Assunta Zocco,
Laura Riccardi, Maurizio Pompili, Gian Ludovico Rapaccini, Antonio Grieco,
Gennaro Nuzzo, Felice Giuliante, Salvatore Agnes, Anna Maria De Gaetano,
Giovanni B. Gasbarrini, Roberto Iezzi, Lorenzo Bonomo, Antonio Gasbarrini,
Comparison Between Transcatheter Arterial Chemoembolization (TACE) and Transcatheter
Arterial Chemoembolization Combined With Percutaneous Radiofrequency Ablation
(TACE-RFA) for Treatment of Intermediate Hepatocellular Carcinoma,
Gastroenterology (Vol.144, Issue 5, Mo2028).
73) Valentina Cesario, Federico Barbaro, Mariachiara Campanale,
Michele La Torre, Alessandra Guerra, Teresa Antonella Di Rienzo, Silvia Pecere,
Francesca Romana Ponziani, Emanuele Rinninella, Giovanni Gigante, Massimo
Siciliano, Brigida E. Annicchiarico, Maria Assunta Zocco, Laura Riccardi,
Maurizio Pompili, Gian Ludovico Rapaccini, Antonio Grieco, Gennaro Nuzzo,
Felice Giuliante, Salvatore Agnes, Anna Maria De Gaetano, Giovanni B.
Gasbarrini, Roberto Iezzi, Lorenzo Bonomo, Antonio Gasbarrini. Treatment of
Single- Nodule Hepatocellular Carcinoma: Comparison Between Surgical Resection
and Transcatheter Arterial Chemioembolization Combined With Percutaneous
Radiofrequency (TACE-RFA). Gastroenterology (Vol.144, Issue 5, Mo2024)
74) Giovanni Gigante, Gianluigi Caracciolo, Gianluca Ianiro,
Annalisa Tortora, Mariachiara Campanale, Valentina Cesario, Venanzio Valenza,
Giovanni Cammarota, Veronica Ojetti, Giovanni Gasbarrini, Antonio Gasbarrini,
Efficacy of Amytriptiline in Improving Intestinal Permeability and Quality of
Life in Patients With IBS, Gastroenterology (Vol.142, Issue 5, Sa1422).
75) Roberto lezzi, Valentina Cesario, Mariachiara Campanale,
Teresa Antonella Di Rienzo, Giovanni Gigante, Gianluigi Caracciolo, Emanuele
Rinninella, Francesca Romana Ponziani, Michele La Torre, Brigida E.
Annicchiarico, Massimo Siciliano, Maurizio Pompili, Antonio Grieco, Luca Miele,
Gian Ludovico Rapaccini, Laura Riccardi, Maria Assunta Zocco, Alessandro
Milani, Marco Santoro, Anna Maria De Gaetano, Giovanni B. Gasbarrini, Lorenzo
Bonomo, Antonio Gasbarrini, Single-Step Balloon-Occluded Percutaneous
Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial
Chemoembolization (TACE) for Treatment of “Complex†Unresectable Hepatocellular Carcinoma, Gastroenterology (Vol.142,
Issue 5, Su1224).
76) Roberto lezzi, Valentina Cesario, Mariachiara Campanale,
Silvia Pecere, Giovanni Gigante, Gianluigi Caracciolo, Teresa Antonella Di
Rienzo, Emanuele Rinninella, Francesca Romana Ponziani, Federico Barbaro,
Brigida E. Annicchiarico, Massimo Siciliano, Maurizio Pompili, Gian Ludovico Rapaccini,
Michele La Torre, Marco Santoro, Antonio Grieco, Luca Miele, Laura Riccardi,
Maria Assunta Zocco, Alessandro Milani, Anna Maria De Gaetano, Giovanni B.
Gasbarrini, Lorenzo Bonomo, Antonio Gasbarrini. Single-Step Combined Therapy
for Treatment of Sngle Large Unresectable Hepatocellular Carcinoma:
Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus
Transcatheter Arterial Chemoembolization (TACE). Initial Results,
Gastroenterology (Vol.142, Issue 5, Su1226)
77)Â Roberto lezzi, Valentina Cesario, Mariachiara
Campanale, Silvia Pecere, Federico Barbaro, Emanuele Rinninella, Giovanni
Gigante, Francesca Romana Ponziani, Michele La Torre, Brigida E. Annicchiarico,
Massimo Siciliano, Maurizio Pompili, Antonio Grieco, Luca Miele, Gian Ludovico
Rapaccini, Laura Riccardi, Maria Assunta Zocco, Alessandro Milani, Anna Maria
De Gaetano, Giovanni B. Gasbarrini, Lorenzo Bonomo, Antonio Gasbarrini, New
Therapeutic Perspectives for Management of Advanced Hepatocellular Carcinoma
With Hepatic Arteriovenous Fistula: Balloon-Occluded Percutaneous
Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial
Chemoembolization (TACE), Gastroenterology (Vol.142, Issue 5, Su1222)
78) Roberto lezzi, Valentina Cesario, Mariachiara Campanale,
Silvia Pecere, Federico Barbaro, Teresa Antonella Di Rienzo, Giovanni Gigante
Emanuele Rinninella, Francesca Romana Ponziani, Michele La Torre, Brigida E.
Annicchiarico, Massimo Siciliano, Maurizio Pompili, Antonio Grieco, Luca Miele,
Gian Ludovico Rapaccini, Laura Riccardi, Maria Assunta Zocco, Marco Santoro,
Alessandro Milani, Anna Maria De Gaetano, Giovanni B. Gasbarrini, Lorenzo
Bonomo, Antonio Gasbarrini, Single-Step Combined Therapy for Treatment of
Multinodular Unresectable Hepatocellular Carcinoma: Balloon-Occluded
Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial
Chemoembolization (TACE). Initial Results and Medium-Term Follow-up,
Gastroenterology (Vol.142, Issue 5, Su1225). 79)Â Giovanni Bruno,
Francesca D'Aversa, Viviana Gerardi, Teresa Antonella Di Rienzo, Annalisa
Tortora, Gianluca Ianiro, Giovanni Gigante, Gianluigi Caracciolo, Veronica
Ojetti, Giovanni Gasbarrini, Antonio Gasbarrini The Prevalence of “H2 Non
Producer†in IBS Population, Gastroenterology (Vol.142, Issue 5
Su1195)
80) Francesca Romana Ponziani, Maria Assunta Zocco, Francesca
D'Aversa, Matteo Garcovich, Annalisa Tortora, Anna Maria De Gaetano, Gianluigi
Caracciolo, Giovanni Gigante, Valentina Cesario, Emanuele Rinninella, Gianluca
Ianiro, Mariachiara Campanale, Teresa Antonella Di Rienzo, Massimo Siciliano,
Brigida E. Annicchiarico, Alessandro Milani, Giovanni Gasbarrini, Salvatore
Agnes, Antonio Grieco, Gennaro Nuzzo, Felice Giuliante, Maurizio Pompili, Gian
Ludovico Rapaccini, Antonio Gasbarrini, Lack of Response and Tumor Recurrence
After Multimodal Repeated Treatment for Hepatocellular Carcinoma Similarly
Affect HCC Patients Survival. the Hepatocat Group Experience, Gastroenterology (Vol.142,
Issue 5, Su2045), 81) Francesco Franceschi, Annalisa Tortora, Mariachiara
Campanale, Flavio Bertucci, Silvia Pecere, Viviana Gerardi, Federico Barbaro,
Giovanni Gigante, Valentina Cesario, Paolo Iacomini, Anna Granato, Chiara
Cordischi, Marta Sabbatini, Niccolò Gentiloni Silveri, Diego Curro', Giovanni
Cammarota, Giovanni Gasb rrini, Antonio Gasbarrini, High Dose Amoxicillin-Based
First Line Regimen Compared to Sequential Therapy in the Eradication of H.
pylori Infection, Gastroenterology (Vol.142, Issue 5, Su1714), 82)
Valentina Cesario, Teresa Antonella Di Rienzo, Mariachiara Campanale, Federico
Barbaro, Giovanni Gigante, Annalisa Tortora, Giovanna Vitale, Giuseppe Scavone,
Dario Pitocco, Giovanni B. Gasbarrini, Antonio Gasbarrini, Veronica Ojetti,
High Level of Methanogenic Flora in Patients Affected by Poorly Controlled Type
I Diabetes, Gastroenterology (Vol.142, Issue 5, Su1941).
83) Veronica Ojetti, Flavio Bertucci, Gianluca Ianiro, Annalisa
Tortora, Francesco Buccelletti, Viviana Gerardi, Daniele Ferrarese, Emidio
Scarpellini, Maurizio Gabrielli, Giovanni Gigante, Antonio Gasbarrini, The
Impact of Anxiety on Lactose Intolerance Symptoms, Gastroenterology (Vol.142,
Issue 5, Su1197).
84) Emidio Scarpellini, Eleonora Nucera, Mariachiara Campanale,
Venanzio Valenza, Giovanni Gigante, Annalisa Tortora, Veronica Ojetti, Domenico
Schiavino, Antonio Gasbarrini, Intestinal Permeability in Nickel Allergy,
Gastroenterology (Vol.142, Issue 5, Tu1354).
85) Francesco Franceschi, Mariachiara Campanale, Rosalba Finizio,
Federico Barbaro, Annalisa Tortora, Giovanni Gigante, Valentina Cesario, Sara
Calcinaro, Davide Marsiliani, Annarita Carroccia, Niccolò Gentiloni Silveri,
Diego Currò, Giovanni Cammarota, Giovanni Gasbarrini, Antonio Gasbarrini, High
Dose Amoxicillin-Based First Line Regimen is Equivalent to Sequential Therapy
in the Eradication of H. pylori Infection, Gastroenterology (Vol.140, Issue 5).
86) Maria Elena Ainora, Maria Assunta Zocco, Francesca R.
Ponziani, Roberto Iezzi, Carmine Di Stasi, Brigida E. Annicchiarico, Annalisa
Tortora, Valentina Cesario, Giovanni Gigante, Gianluigi Caracciolo, Anna Maria
De Gaetano, Massimo Siciliano, Giovanni Gasbarrini, Lorenzo Bonomo, Antonio
Gasbarrini, Hepatic Decompensation After Transarterial Chemoembolization for
Hepatocellular Carcinoma: Predictive Value of MELD and MELD-Na,
Gastroenterology (Vol.140, Issue 5).
87) Emidio Scarpellini, Valentina Giorgio, Maurizio Gabrielli,
Simona Filoni, Giovanna Vitale, Annalisa Tortora, Giovanni Gigante, Veronica
Ojetti, Giovanni Gasbarrini, Carlo Fundarò, Antonio Gasbarrini Rifaximin
Treatment for Small Intestinal Bacterial Overgrowth in Children With Irritable
Bowel Syndrome, Gastroenterology (Vol.140, Issue 5).
88) Francesco Franceschi, Rosalba Finizio, Mariachiara Campanale,
Federico Barbaro, Giovanni Gigante, Luca Santarelli, Valentina Cesario,
Annalisa Tortora, Sara Calcinaro, Davide Marsiliani, Annarita Carroccia,
Niccolò Gentiloni Silveri, Diego Currò, Giovanni Cammarota, Giovanni
Gasbarrini, Antonio Gasbarrini, Sequential and Standard Levofloxacin-Based H.
pylori Eradicating Regimens Compared to Quadruple Therapy: Effect of
Levofloxacin Dosage and Way of Administration. Gastroenterology (Vol.140, Issue
5)
89) Emidio Scarpellini, Valentina Giorgio, Simona Filoni, Veronica
Ojetti, Maurizio Gabrielli, Giovanni Gigante, Ernesto Cristiano Lauritano,
Federico Barbaro, Giovanni Gasbarrini, Carlo Fundarò, Antonio Gasbarrini,
Efficacy of Rifaximin for SIBO Treatment in IBS Children, Gastroenterology
(Vol.138, Issue 5, W1907).
90) Ercole de Masi, Francesco Franceschi, Maria A. Mancini,
Giovanni Cammarota, Immacolata A. Cazzato, Davide Roccarina, Giovanni Gigante,
Bianca Giupponi, Guido de Marco, Antonio Gasbarrini, Nicolò Gentiloni Silveri,
Giovanni Gasbarrini, Metabolic Syndrome Promotes the Occurrence of
Pre-Neopastic Lesions of the Colonic Mucosa, Gastroenterology (Vol.138, Issue
5, S1976)
91) Maria Assunta Zocco, Andrea Lupascu, Laura Riccardi, Anna C.
Piscaglia, Luisa Siciliani, Marialuisa Novi, Ernesto Cristiano Lauritano,
Annalisa Tortora, Giovanni Gigante, Michele Cosimo Santoro, Emanuele
Rinninella, Maria Elena Ainora, Francesca R. Ponziani, Maurizio Pompili, Gian
Ludovico Rapaccini, Antonio Gasbarrini, Dynamic Contrast Enhanced Ultrasound in
Monitoring HCC Patients Treated With Sorafenib: Preliminary Results,
Gastroenterology (Vol.138, Issue 5, S1903)
92)Â G. Gigante, G. Caracciolo, M. Campanale, V. Cesario, G.
Gasbarrini, G. Cammarota, A. Gasbarrini, GELATINE TANNATE REDUCES ANTIBIOTICS
ASSOCIATED SIDE-EFFECTS OF ANTI-HELICOBACTER PYLORI FIRST-LINE THERAPY,
Digestive and Liver Disease (Vol.45, P.09.7)
93) G. Gigante, G. Caracciolo, G. Ianiro, A. Tortora, M.
Campanale, V. Cesario, V. Valenza, G. Cammarota, V. Ojetti, G. Gasbarrini, A.
Gasbarrini EFFICACY OF AMYTRIPTILINE IN IMPROVING INTESTINAL PERMEABILITY AND
QUALITY OF LIFE IN PATIENTS WITH IB. Digestive and Liver Disease (Vol.45,
P.06.16).Â
94) F.R. Ponziani, M.A. Zocco, M. Garcovich, V. Cesario, F.
D'Aversa, T.A. Di Rienzo, A.M. De Gaetano, E. Rinninella, D. Roccarina, M.
Campanale, F. Barbaro, A. Tortora, G. Caracciolo, G. Gigante, G. Ianiro, M.
Siciliano, B.E. Annicchiarico, A. Milani, R. Zaccaria, G. Sarno, G. Gasbarrini,
S. Agnes, A.W. Avolio, A. Grieco, G. Nuzzo, F. Giuliante, M. Pompili, G.L.
Rapaccini, A. Gasbarrini. IMPACT OF PORTAL VEIN THROMBOSIS ON HEPATOCELLULAR
CARCINOMA TREATMENT OUTCOME. THE HEPATOCAT GROUP EXPERIENCE Digestive and Liver
Disease (Vol.45, P.11.15).Â
95) V. Ojetti, G. Ianiro, A. Tortora, G. Bruno, L. Laterza, G.
Gigante, F.R. Ponziani, G. Cammarota, A. Gasbarrini. LACTOBACILLUS REUTERI (DSM
17938) FOR THE TREATMENT OF FUNCTIONAL CONSTIPATION IN ADULT PATIENTS: A
DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL Digestive and Liver Disease
(Vol.45, P.06.18)
96) V. Cesario, F. Barbaro, M. Campanale, M. La Torre, A. Guerra,
T.A. Di Rienzo, S. Pecere, G. Gigante, E. Rinninella, F.R. Ponziani, M.
Siciliano, B.E. Annicchiarico, M.A. Zocco, L. Riccardi, M. Pompili, G.L.
Rapaccini, A. Grieco, G. Nuzzo, F. Giuliante, S. Agnes, A.M. De Gaetano, G.B.
Gasbarrini, R. Iezzi, L. Bonomo, A. Gasbarrini TREATMENT OF SINGLE-NODULE
HEPATOCELLULAR CARCINOMA (HCC): COMPARISON BETWEEN SURGICAL RESECTION AND
TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS
RADIOFREQUENCY Digestive and Liver Disease (Vol.45, P.13.5).
97) F.R. Ponziani, M.A. Zocco, M. Garcovich, F. D'Aversa, G.
Gigante, E. Di Stasio, D. Roccarina, A. Gasbarrini, EPIDEMIOLOGY OF PORTAL AND
DEEP VEIN THROMBOSIS IN HOSPITALIZED CIRRHOTIC PATIENTS: A SINGLE CENTER
EXPERIENCE. Digestive and Liver Disease (Vol.45, P.11.13).
98) M. Campanale, F. Barbaro, V. Cesario, M. La Torre, A. Guerra,
T.A. Di Rienzo, F. D'Aversa, G. Gigante, E. Rinninella, F.R. Ponziani, M.
Siciliano, B.E. Annicchiarico, M.A. Zocco, L. Riccardi, M. Pompili, G.L. Rapaccini,
G. Nuzzo, F. Giuliante, A. Grieco, S. Agnes, A.M. De Gaetano, G.B. Gasbarrini,
R. Iezzi, L. Bonomo, A. Gasbarrini. COMPARISON BETWEEN TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION (TACE) AND TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED
WITH PERCUTANEOUS RADIOFREQUENCY ABLATION (TACE-RFA) FOR TREATMENT OF
INTERMEDIATE HEPATOCELLULAR CARCINOMA (HCC), Digestive and Liver Disease
(Vol.45, P.13.7)
99) V. Cesario, F. Barbaro, M. Campanale, M. La Torre, A. Guerra,
T.A. Di Rienzo, S. Pecere, G. Gigante, E. Rinninella, F.R. Ponziani, M.
Siciliano, B.E. Annicchiarico, M.A. Zocco, L. Riccardi, M. Pompili, G.L.
Rapaccini, A. Grieco, G. Nuzzo, F. Giuliante, S. Agnes, A.M. De Gaetano, G.B.
Gasbarrini, R. Iezzi, L. Bonomo, A. Gasbarrini, Treatment of single-nodule
hepatocarcinoma: comparison between surgical resection and transarterial
chemoembolization combined with radiofrequency, Digestive and Liver Disease
(Vol.45, T-43)
100) G. Gigante, F. Bertucci, V. Ojetti, A. Tortora, G.
Caracciolo, M.C. Campanale, V. Cesario, G. Gasbarrini, A. Gasbarrini, A LOWER
QUALITY OF LIFE IN PATIENTS WITH FUNCTIONAL BOWEL DISORDERS COMPARED TO THOSE
WITH GASTRIC DYSPEPSIA, Digestive and Liver Disease (Vol.44, P.07.20)
101) A. Tortora, M. Gabrielli, F. Purchiaroni, V. Ojetti, L. Sparano,
G. Vitale, G. Gigante, E. Scarpellini, A. Gasbarrini, EFFICACY OF RIFAXIMIN IN
THE TREATMENT OF COLONIC BACTERIAL OVERGROWTH IN IBS PATIENTS: PRELIMINARY
RESULTS, Digestive and Liver Disease (Vol.44, P.07.2)
102) T.A. Di Rienzo, V. Cesario, M.C. Campanale, F. Barbaro, G.
Gigante, G. Vitale, G. Caracciolo, G. Scavone, D. Pitocco, A. Gasbarrini, V.
Ojetti HIGH LEVEL OF METHANOGENIC FLORA IN PATIENTS AFFECTED BY POORLY
CONTROLLED TYPE I DIABETES, Digestive and Liver Disease (Vol.44, P.07.12)
103) V. Ojetti, F. Bertucci, G. Ianiro, A. Tortora, F.
Buccelletti, V. Gerardi, D. Ferrarese, E. Scarpellini, M. Gabrielli, G.
Gigante, A. Gasbarrini THE IMPACT OF ANXIETY ON LACTOSE INTOLERANCE SYMPTOMS
Digestive and Liver Disease (Vol.44, P.18.11).
104) E. Scalpellini, E. Nucera, M.C. Campanale, V. Valenza, G.
Gigante, A. Tortora, V. Ojetti, D. Schiavino, A. Gasbarrini, INTESTINAL
PERMEABILITY IN NICKEL ALLERGY, Digestive and Liver Disease (Vol.44, P.11.10)
105) A. Tortora, M.A. Zocco, G. Gigante, M. Garcovich, F.R.
Ponziani, A. Fasano, M. Gabrielli, M. Petracca, P.A. Tonali, A. Gasbarrini,
REAL-TIME EVALUATION OF ALTERED GASTRIC MOTILITY BY ULTRASONOGRAPHY IN PATIENTS
WITH PARKINSON'S DISEASE, Digestive and Liver Disease (Vol.44, P.07.11).
106) V. Cesario, R. Iezzi, M.C. Campanale, E. Rinninella, F.R.
Ponziani, S. Pecere, G. Caracciolo, G. Gigante, B.E. Annicchiarico, M.
Siciliano, M. Pompili, G.L. Rapaccini, A. Grieco, L. Miele, A. Milani, L.
Riccardi, M.A. Zocco, M. Santoro, M. La Torre, A.M. De Gaetano, G.B. Gasbarrini,
L. Bonomo, A. Gasbarrini, SINGLE-STEP COMBINED THERAPY FOR TREATMENT OF SNGLE
LARGE UNRESECTABLE HEPATOCELLULAR CARCINOMA: BALLOON-OCCLUDED PERCUTANEOUS
RADIO-FREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION (TACE). INITIAL RESULTS, Digestive and Liver Disease (Vol.44,
P.15.4)
107) F. Franceschi, A. Tortora, M.C. Campanale, F. Bertucci, S.
Pecere, V. Gerardi, F. Barbaro, G. Gigante, V. Cesario, P. Iacomini, A.
Granato, C. Cordischi, M. Sabbatini, N. Gentiloni Silveri, D. Curro', G.
Cammarota, G. Gasbarrini, A. Gasbarrini, HIGH DOSE AMOXICILLIN-BASED FIRST LINE
REGIMEN COMPARED TO SEQUENTIAL THERAPY IN THE ERADICATION OF H. PYLORI
INFECTION, Digestive and Liver Disease (Vol.44, P.19.14).
108) F.R. Ponziani, M.A. Zocco, F. D'Aversa, M. Garcovich, A.
Tortora, A.M. De Gaetano, G. Caracciolo, G. Gigante, V. Cesario, E. Rinninella,
G. Ianiro, T.A. Di Rienzo, M. Siciliano, B.E. Annicchiarico, A. Milani, R.
Zaccaria, G. Sarno, G. Gasbarrini, S. Agnes, A.W. Avolio, A. Grieco, G. Nuzzo,
G. Giuliante, M. Pompili, G.L. Rapaccini, A. Gasbarrini, LACK OF RESPONSE AND
TUMOR RECURRENCE AFTER MULTIMODAL REPEATED TREATMENT, Digestive and Liver
Disease (Vol.44, P.08.8)
109) F.R. Ponziani, B.E. Annicchiarico, M. Siciliano, C. Barone,
M. Basso, V. Cesario, M.C. Campanale, G. Caracciolo, M. Garcovich, M.A. Zocco,
G. Gigante, E. Rinninella, G. Sarno, T.A. Di Rienzo, F. D'Aversa, G.
Gasbarrini, A. Gasbarrini, REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE
ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA,
Digestive and Liver Disease (Vol.44, P.08.13).
110) G. Bruno, F. D'Aversa, V. Gerardi, T.A. Di Rienzo, A.
Tortora, G. Gigante, G. Gasbarrini, A. Gasbarrini, V. Ojetti, THE PREVALENCE OF
“H2 NON PRODUCER†IN IBS POPULATION, Digestive and Liver Disease (Vol.44,
P.07.9)
111) V. Cesario, R. Iezzi, M.C. Campanale, E. Rinninella, F.R.
Ponziani, S. Pecere, G. Gigante, G. Caracciolo, B.E. Annicchiarico, M.
Siciliano, G.L. Rapaccini, M. Pompili, A. Grieco, L. Miele, L. Riccardi, A.
Milani, M.A. Zocco, M. La Torre, M. Santoro, A.M. De Gaetano, G.B. Gasbarrini,
L. Bonomo, A. Gasbarrini, SINGLE-STEP BALLOON-OCCLUDED PERCUTANEOUS
RADIO-FREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION (TACE) FOR TREATMENT OF “COMPLEX†UNRESECTABLE HEPATOCELLULAR CARCINOMA, Digestive and Liver
Disease (Vol.44, P.03.12)
112) R. Iezzi, V. Cesario, M. Campanale, T.A. DiRienzo, G.
Gigante, G. Caracciolo, E. Rinninella, F.R. Ponziani, M. La Torre, B.E.
Annicchiarico, M. Siciliano, M. Pompili, A. Grieco, L. Miele, M. Santoro, G.L.
Rapaccini, L. Riccardi, M.A. Zocco, A. Milani, A.M. De Gaetano, G. Gasbarrini,
L. Bonomo, A. Gasbarrini Single-step balloon-occluded percutaneous
radio-frequency thermal ablation (RFA) plus transcatheter arterial
chemoembolization (TACE) for treatment of “complex†unresectable hepatocellular carcinoma, Digestive and Liver
Disease (Vol.44, T-21).
113) F.R. Ponziani, M.A. Zocco, A.M. De Gaetano, A. Milani, M.
Garcovich, G. Caracciolo, V. Cesario, V. Gigante, A. Tortora, C. Campanale, F.
D'Aversa, T.A. DiRienzo, R. Zaccaria, E. Rinninella, M. Siciliano, B.E.
Annicchiarico, G. Sarno, G. Gasbarrini, S. Agnes, A. Grieco, G. Nuzzo, M.
Pompili, G.L. Rapaccini, F. Giuliante, A. Gasbarrini, HEPATOCAT Group for the
Multidisciplinary Management of HCC, Lack of response and tumor recurrence
after multimodal repeated treatment for hepatocellular carcinoma similarly
affect HCC patients survival. A HEPATOCAT group experience, Digestive and Liver
Disease (Vol.44, F-23)
114) F.R. Ponziani, B.E. Annicchiarico, M. Siciliano, C. Barone,
M. Basso, V. Cesario, M. Campanale, G. Caracciolo, M. Garcovich, M.A. Zocco, G.
Gigante, E. Rinninella, G. Sarno, T.A. DiRienzo, F. D'Aversa, G. Gasbarrini, A.
Gasbarrini, Short treatment with sorafenib is associated to tumor progression
in patients with hepatocellular carcinoma, Digestive and Liver Disease (Vol.44,
F-24).
115) F.R. Ponziani, M.A. Zocco, A.M. De Gaetano, M.L. Novi, M.
Siciliano, A. Milani, B.E. Annicchiarico, E. Rinninella, G. Gigante, V.
Cesario, G. Caracciolo, A. Tortora, M. Garcovich, G. Gasbarrini, S. Agnes, G.
Bombardieri, A. Grieco, G. Nuzzo, M. Pompili, G.L. Rapaccini, F. Giuliante, E.
Di Stasio, A. Gasbarrini, HEPATOCAT Group, HCC PERSONALIZED TREATMENT IN THE
MULTIMODAL MANAGEMENT ERA: HEPATOCAT GROUP EXPERIENCE, Digestive and Liver
Disease (Vol.43, P.1.161).
116) F. Franceschi, R. Finizio, M. Campanale, F. Barbaro, G.
Gigante, A. Tortora, L. Santarelli, V. Cesario, S. Calcinaro, D. Marsiliani, A.
Carroccia, N. Gentiloni Silveri, D. Currò, G. Cammarota, G. Gasbarrini, G.
Bombardieri, A. Gasbarrini. SEQUENTIAL AND STANDARD LEVOFLOXACIN-BASED H.
PYLORI ERADICATING REGIMENS COMPARED TO QUADRUPLE THERAPY: EFFECT OF
LEVOFLOXACIN DOSAGE AND WAY OF ADMINISTRATION, Digestive and Liver Disease
(Vol.43, P.1.38)
117) F. Franceschi, M. Campanale, R. Finizio, F. Barbaro, A.
Tortora, G. Gigante, V. Cesario, S. Calcinaro, D. Marsiliani, A. Carroccia, N.
Gentiloni Silveri, D. Currò, G. Cammarota, G. Gasbarrini, G. Bombardieri, A.
Gasbarrini HIGH DOSE AMOXICILLIN-BASED FIRST LINE REGIMEN IS EQUIVALENT TO
SEQUENTIAL THERAPY IN THE ERADICATION OF H. PYLORI INFECTION. Digestive and
Liver Disease (Vol.43, P.1.303)
118) M. Ainora, M. Zocco, F. Ponziani, R. Iezzi, C. Di Stasi, B.
Annicchiarico, A. Tortora, V. Cesario, G. Gigante, G. Caracciolo, A. De
Gaetano, M. Siciliano, G. Gasbarrini, L. Bonomo, A. Gasbarrini, HEPATIC
DECOMPENSATION AFTER TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR
CARCINOMA: PREDICTIVE VALUE OF MELD AND MELD-NA, Digestive and Liver Disease
(Vol.43, P.1.94)
119) E. Scarpellini, V. Giorgio, M. Gabrielli, S. Filoni, G.
Vitale, A. Tortora, G. Gigante, V. Ojetti, G.B. Gasbarrini, C. Fundarò, A.
Gasbarrini, RIFAXIMIN TREATMENT FOR SMALL INTESTINAL BACTERIAL OVERGROWTH IN
CHILDREN WITH IRRITABLE BOWEL SYNDROME, Digestive and Liver Disease (Vol.43,
P.1.148)
120)Â R. Iezzi, V. Cesario, F.R. Ponziani, G. Gigante, E.
Rinninella, C. Campanale, T.A. Di Rienzo, G. Caracciolo, M.A. Zocco, A.M. De
Gaetano, M. Siciliano, A. Milani, L. Miele, A. Grieco, S. Agnes, G.
Bombardieri, G. Nuzzo, F. Giuliante, M. Pompili, G.L. Rapaccini, M. Basso, G.
Gasbarrini, L. Bonomo, A. Gasbarrini, NEW PERSPECTIVES IN TREATMENT OF
MULTINODULAR UNRESECTABLE HEPATOCELLULAR CARCINOMA: BALLOON-OCCLUDED
PERCUTANEOUS RADIO-FREQUENCY THERMOABLATION (RFA) FOLLOWED BY TRANSCATHETER
ARTERIAL CHEMOEMBOLIZATION (TACE), Digestive and Liver Disease (Vol.43,
P.1.175).
121) F. Franceschi, M. Marini, A. Piscaglia, N. Soulier, A.
Puglisi, R. Ricci, B. Giupponi, G. De Marco, D. Roccarina, G. Gigante, F.
Barbaro, F. Mancini, N. Gentiloni Silveri, G. Gasbarrini, A. Gasbarrini, EFFECT
OF BACILLUS CLAUSII ADMINISTRATION IN THE RECTAL MUCOSA OF MICE TREATED WITH
INTRARECTAL INSTILLATION OF THE CARCINOGEN N-METHYLNITROSUREA, Digestive and
Liver Disease (Vol.42, P.107).
122) M. Zocco, A. Lupascu, L. Riccardi, A. Piscaglia, L.
Siciliani, M. Novi, E.C. Lauritano, A. Tortora, G. Gigante, M. Santoro, E. Rinninella,
M. Ainora, F. Ponziani, M. Pompili, G. Rapaccini, A. Gasbarrini, DYNAMIC
CONTRAST ENHANCED ULTRASOUND IN MONITORING HCC PATIENTS TREATED WITH SORAFENIB:
PRELIMINARY RESULTS, Digestive and Liver Disease (Vol.42, P.135).
123) M. Zocco, M. Ainora, A. Lupascu, A. Tortora, G. Gigante, F.
De Vincentis, I.A. Cazzato, A. Piscaglia, F. Ponziani, P. Tondi, G.
Bombardieri, A. Gasbarrini, ROLE OF DYNAMIC CONTRAST ENHANCED ULTRASOUND IN THE
FOLLOW UP OF CROHN'S DISEASE PATIENTS UNDER CORTICOSTEROID TREATMENT, Digestive
and Liver Disease (Vol.42, P.88).
124) E. De Masi, F. Franceschi, M. Mancino, G. Cammarota, I.A.
Cazzato, D. Roccarina, G. Gigante, B. Giupponi, G. De Marco, A. Gasbarrini, N.
Gentiloni Silveri, G. Gasbarrini, METABOLIC SYNDROME PROMOTES THE OCCURRENCE OF
PRE-NEOPASTIC LESIONS OF THE COLONIC MUCOSA, Digestive and Liver Disease
(Vol.42, OC.06.3).
125) M.A. Zocco, A. Lupascu, L. Riccardi, A.C. Piscaglia, L.
Siciliani, M. Novi, E.C. Lauritano, A. Tortora, G. Gigante, M. Santoro, E.
Rinninella, M.E. Ainora, F. Ponziani, M. Pompili, G.L. Rapaccni, A. Gasbarrini,
DYNAMIC CONTRAST ENHANCED ULTRASOUND IN MONITORING HCC PATIENTS TREATED WITH
SORAFENIB: PRELIMINARY RESULTS, Digestive and Liver Disease (Vol.42, T.N.19).
126) G. Gigante, G. ,Caracciolo, M. Campanale, V. Cesario, M. E.
Ainora, V. Bove, V. Ojetti, G. Gasbarrini, A. Gasbarrini, EFFICACY OF
AMYTRIPTILINE IN IMPROVING INTESTINAL PERMEABILITY AND QUALITY OF LIFE IN
PATIENTS WITH IBS , UEG Journal Vol.1, Suppl. 1, OP159: Oct 2013.
127) V. Cesario, T. A. Di Rienzo, D. Pitocco, M. Campanale, G.
D’Angelo, S. Pecere, F. D’Aversa, A. Tortora, F. Barbaro, G. Vitale, G.
Gigante, G. Caracciolo1, A. Gasbarfrini1, V. Ojetti., DIABETES AND
GASTROINTESTINAL DISORDERS: THE EFFECT OF INTESTINAL METHANE PRODUCTION ON
GLYCEMIC CONTROL, UEG Journal Vol.1, Suppl. 1, OP250: Oct 2013
128) G. Gasbarrini 1 , G. Ianiro, M. Amici, R. Castellani, V.
Palmieri,F. Scaldaferri, F. Beghella Bartoli, G. Gigante, C. Tersigni, M. De
SpiritoN. Di Simone,, A. Gasbarrini2, MORPHOLOGICAL FEATURES OF ENDOTHELIAL
CELLS OF ENDOMETRIUM BEFORE AND AFTER INCUBATION WITH ANTITRANSGLUTAMINASE
ANTIBODIES IN BOTH HEALTHY AND CELIAC WOMEN, UEG Journal Vol.1, Suppl. 1, P546:
Oct 2013
129) G. Ianiro1,*Â E. Dal Toma , A. Vitale, F. Beghella
Bartoli, S. De Martino,G. Dinoi, G. Gigante, G. Cammarota, G. Gasbarrini A.
Gasbarrini,G.Da Villa, P548 WHITE MULBERRY SUPPLEMENTATION AS ADJUVANT
TREATMENT OF OBESITY., UEG Journal Vol.1, Suppl. 1, P548: Oct 2013
130) G. Gigante, G. Caracciolo, M. Campanale, V. Cesario, M. E.
Ainora, V. Bove, V. Ojetti, G. Gasbarrini, A. Gasbarrini, GELATINE TANNATE
SUPPLEMENTATION REDUCES ANTIBIOTICS ASSOCIATED SIDE-EFFECTS OF ANTIHELICOBACTER
PYLORI FIRST-LINE THERAPY, UEG Journal Vol.1, Suppl. 1, P1077: Oct 2013.
131) G. Ianiro1,*Â E. Dal Toma , A. Vitale, F. Beghella
Bartoli, S. De Martino,G. Dinoi, G. Gigante, G. Cammarota, G. Gasbarrini A.
Gasbarrini, A COMBINATION OF PRE- AND PROBIOTICS, VITAMINS, MINERALS,
ANTIOXIDANTS AND ANTI-INFLAMMATORY AGENTS AS A NEW THERAPEUTIC APPROACH FOR
INCREASED INTESTINAL PERMEABILITY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
WITHOUT CONSTIPATION, UEG Journal Vol.1, Suppl. 1, P1109: Oct 2013.
132) P. Familiari,M. Marchese, G. Gigante, I. Boskoski, A.
Tringali, V. Bove,C. Marmo, R. Landi, V. Perri, G. Costamagna, CLINICAL AND
PROCEDURAL FACTORS PREDICTIVE OF COMPLETE SYMPTOMS RELIEF AFTER PERORAL
ENDOSCOPIC MYOTOMY (POEM). RESULTS OF A SINGLE CENTER EXPERIENCE, UEG Journal
Vol.1, Suppl. 1, P1130: Oct 2013.
133) V. Bove, A. Tringali, I. Bosˇkoski, G. Gigante, P.
Familiari, V. Perri,C. Marmo, R. Landi, M. Mutignani, G. Costamagna.
ERCP IN PATIENTS WITH PRIOR BILLROTH II GASTRECTOMY: REPORT OF A 30- YEAR
EXPERIENCE, UEG Journal Vol.1, Suppl. 1, P1316: Oct 2013.
BOOK CHAPTERS
1) G. Ianiro, G. Gigante, M. Pizzoferrato, Ruolo del Microbiota
nelle Malattie dell’ Apparato Digerente : Sindrome dell’ Intestino
Irritabile, Sezione II “ Il Microbiota Intestinale†Verduci editore 2013; pp 15-17
2) G. Gigante, G. ianiro, V. Ojetti Ruolo del Microbiota
Intestinale nelle Malattie Metaboliche : Obesità , Sezione III “ Il
Microbiota Intestinale†Verduci editore 2013; pp 41-45
3) G. Gasbarrini, F. Franceschi, G. Gigante L’impiego della
claritromicina in Gastroenterologia: Il trattamento dell’infezione da H.
Pylori, Percorsi Terapeutici attuali in Antibiotico Terapia†volume depositato AIFA 15-10-2007; cap V; pp 33-38.